임상시험 트래커

추적 기업 30곳의 임상 6,982건 (국내 전체 이력 · 글로벌 진행 중). 출처: ClinicalTrials.gov

60건 표시 (상위 60건)

2상모집 예정· Central Serous Chorioretinopathy (CSC)
만성 중심성 장액성 맥락막망막병증에서의 파리시맙: 무작위 대조 임상시험
Faricimab for Chronic Central Serous Chorioretinopathy: A Randomized Sham-Controlled Trial
협력: 로슈
상세 →NCT07681167
2상모집 예정· Relapsed /Refractory DLBCL
Radiotherapy in Combination With Glofitamab in Relapsed/Refractory Diffuse Large B Cell Lymphoma
협력: 로슈
상세 →NCT07634289
2상모집 예정· Lymphocytic Leukemia
Phase 2 Study Of Mosunetuzumab In Patients With Chronic Lymphocytic Leukemia With Positive MRD
협력: 로슈
상세 →NCT07566364
2상모집 예정· Obesity or Overweight
A Dose-Finding Study of Petrelintide With Enicepatide (RO7795068) in Adults With Obesity or Overweight
리드: 로슈
상세 →NCT07589686
2상모집 예정· Advanced Lung Non-Small Cell Carcinoma
SX-682 and Atezolizumab for the Treatment of Advanced or Metastatic, Recurrent Non-small Cell Lung Cancer
협력: 로슈
상세 →NCT07322341
2상모집 예정· Acute Myeloid Leukemia
A Study of Azacitidine and Venetoclax Versus a Stem Cell Transplant in People 65 Years and Older With Acute Myeloid Leukemia
협력: 로슈
상세 →NCT06903702
2상모집 예정· Relapsing-remitting Multiple Sclerosis
A Study to Evaluate Pharmacokinetics, Safety, Tolerability, Immunogenicity and Pharmacodynamic Effects of Subcutaneous Ocrelizumab Administration in Children and Adolescents With Relapsing-remitting Multiple Sclerosis (RRMS)
리드: 로슈
상세 →NCT07503340
2상모집 중· HER2-positive Metastatic Breast Cancer
HER2 Molecular Imaging With 89Zr-trastuzumab PET/CT as a Predictive Biomarker for Antibody-drug Conjugate Sequencing in Patients With Advanced HER2-positive Breast Cancer
협력: 로슈
상세 →NCT06595563
2상모집 중· Atherosclerosis
A Study to Evaluate the Efficacy, Safety, Pharmacodynamics (PD), and Pharmacokinetics (PK) of Selnoflast in Reducing Vascular Inflammation in Participants With Atherosclerosis at Risk for Major Adverse Cardiac Events
리드: 로슈
상세 →NCT07448038
2상모집 중· Chronic Lymphocytic Leukemia (CLL)
Phase 2 Study of Disease Risk Mutation-Guided Finite Acalabrutinib+Venetoclax for Relapsed CLL Post-1L Finite cBTKi+BCL2i ± Obinutuzumab
리드: 아스트라제네카 · 협력: 애브비, 로슈
상세 →NCT07024706
2상모집 중· Rheumatoid Arthritis
An Extension Study to Assess Long-Term Safety and Efficacy of Afimkibart in Participants With Rheumatoid Arthritis
리드: 로슈
상세 →NCT07620392
2상모집 예정· Waldenstrom Macroglobulinemia
Mosunetuzumab in Combination With Pirtobrutinib in Patients With Relapsed or Refractory Waldenstrom Macroglobulinemia (MPOWER)
협력: 일라이 릴리, 로슈
상세 →NCT07548450
2상모집 예정· Breast Cancer
A Phase ll, Interventional, Single-arm Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib and Fulvestrant in Chinese Patients With PIK3CA-mutant, HR-positive, HER2-negative Locally Advanced or Metastatic Breast Cancer.
협력: 노바티스, 로슈
상세 →NCT07618390
2상모집 중· Lupus
A Study to Evaluate Mosunetuzumab in Participants With Systemic Lupus Erythematosus With or Without Active Lupus Nephritis
리드: 로슈
상세 →NCT07598396
2상모집 중· High Grade Glioma
Entrectinib as a Single Agent in Upfront Therapy for Children <3 Years of Age With NTRK1/2/3 or ROS1-FUSED CNS Tumors
협력: 로슈
상세 →NCT06528691
2상모집 예정· Diffuse Large B Cell Lymphoma
TPG: Tafasitamab, Polatuzumab Vedotin, and Glofitamab as First-line Therapy for Diffuse Large B-cell Lymphoma and High-grade B-cell Lymphoma
협력: 로슈
상세 →NCT07502872
2상모집 중· Hypertension
A Study to Evaluate ALN-AGT01 RVR in Adult Patients With Mild to Moderate Hypertension Pretreated With Zilebesiran
협력: 로슈
상세 →NCT07553442
2상모집 중· Breast Cancer
A Phase II Study Evaluating the Efficacy and Safety of Inavolisib Plus Ribociclib Plus Fulvestrant Versus Placebo Plus Ribociclib Plus Fulvestrant in Participants With Advanced Breast Cancer
리드: 로슈
상세 →NCT07405801
2상모집 중· Metastatic Castration-Resistant Prostate Cancer
A Study to Test Inavolisib Treatment in Participants With Metastatic Castration-Resistant Prostate Cancer
리드: 로슈
상세 →NCT07287150
2상모집 중· Progressive Multiple Sclerosis
A Study to Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Efficacy of RO7268489 as Add-on Therapy to Ocrelizumab, in Participants With Progressive Forms of Multiple Sclerosis (MS)
리드: 로슈
상세 →NCT07282574
2상모집 중· Breast Cancer
To Study the Effect of Inavolisib in Combination With Fulvestrant in Participants With Breast Cancer
리드: 로슈
상세 →NCT07368998
2상모집 중· Chronic Obstructive Pulmonary Disease (COPD)
Clinical Trial of Omalizumab for Allergen Sensitized and Exposed Individuals With COPD
협력: 로슈
상세 →NCT07059091
2상모집 중· Atopic Dermatitis
A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic Dermatitis
리드: 로슈
상세 →NCT07223697
2상모집 중· Acute Ischemic Stroke From Large Vessel Occlusion
Intra-Arterial Tenecteplase to Improve the Microvascular Hemodynamics After Mechanical Thrombectomy
협력: 로슈
상세 →NCT06904911
2상모집 중· Rheumatoid Arthritis
A Study to Assess the Efficacy and Safety of RO7790121 in Participants With Moderate to Severe Rheumatoid Arthritis Who Have Not Responded to or Who Cannot Tolerate Tumor Necrosis Factor (TNF) and/or Janus Kinase (JAK Inhibitors)
리드: 로슈
상세 →NCT07137598
2상모집 중· Multiple Sclerosis
A Study to Assess Bioequivalence of Two Subcutaneous (SC) Formulations of Ocrelizumab in Participants With Multiple Sclerosis (MS)
리드: 로슈
상세 →NCT07074886
2상모집 중· Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort C: Bevacizumab
협력: 로슈
상세 →NCT06701656
2상모집 예정· Follicular Lymphoma
A Phase 2, Multicenter, Open-Label Trial to Evaluate Efficacy and Safety of Subcutaneous (SC) Mosunetuzumab in Previously Untreated Low Tumor Burden Follicular Lymphoma (LTB-FL).
협력: 로슈
상세 →NCT07191249
2상모집 중· Relapsing Multiple Sclerosis
A Pharmacokinetics (PK), Pharmacodynamics (PD), Safety and Tolerability Study of Fenebrutinib in Children and Adolescents With Relapsing Multiple Sclerosis (RMS)
리드: 로슈
상세 →NCT07161258
2상모집 중· Ulcerative Colitis
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics (PK) of RO7837195 in Participants With Moderately to Severely Active Ulcerative Colitis (UC)
리드: 로슈
상세 →NCT06979336
2상초청 등록· Acute Ischemic Stroke
Intra-Arterial Tenecteplase Following Endovascular Thrombectomy for Large Vessel Occlusion Stroke
협력: 로슈
상세 →NCT06781385
2상모집 중· Soft Tissue Sarcoma
SATURN-STS: Phase II Study of Neoadjuvant Atezolizumab With Doxorubicin, Concurrent Atezolizumab With Pre-operative Radiation Therapy and Adjuvant Atezolizumab in Patients With High-risk Surgically Resectable Extremity and Truncal Soft Tissue Sarcoma
협력: 로슈
상세 →NCT07049848
2상모집 중· Breast Cancer
A Study to Test Inavolisib Treatments in Participants With Early-Stage, PIK3CA-Mutated Breast Cancer
리드: 로슈
상세 →NCT07054190
2상모집 중· Diffuse Large B-Cell Lymphoma (DLBCL)
A Study to Evaluate the Impact of Mosunetuzumab Consolidation for Older Patients With Diffuse Large B-cell Lymphoma (DLBCL) Who Have Detectable Amounts of ctDNA (Circulating Tumor DNA) at the End of Treatment With Pola-R-mini-CHP
협력: 로슈
상세 →NCT06828991
2상모집 중단 (진행 중)· Type 2 Diabetes Mellitus
A Study to Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes
리드: 로슈
상세 →NCT07112872
2상모집 중단 (진행 중)· Obesity or Overweight
A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
리드: 로슈
상세 →NCT07081958
2상모집 중· Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort A: Vilobelimab
협력: 로슈
상세 →NCT06701682
2상모집 중· Stage I Colon Cancer
Phase II Open-label Trial of Neoadjuvant Immunochemotherapy for Resectable Non-metastatic Colon cancER: NICER
협력: 로슈
상세 →NCT05870800
2상모집 중· Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS (Master Record)
협력: 로슈
상세 →NCT06703073
2상모집 중· Acute Respiratory Distress Syndrome (ARDS)
JUST BREATHE, Breathing Life Into Innovative Therapies for ARDS- Cohort B: Paridiprubart
협력: 로슈
상세 →NCT06701669
2상모집 예정· Diffuse Large B-Cell Lymphoma
Glofitamab, Polatuzumab Vedotin and Zanubrutinib in First-line Elderly DLBCL
협력: 로슈
상세 →NCT07012980
2상모집 중· Food Hypersensitivity
Omalizumab for the Treatment of Food Allergy in Patients With Elevated Total IgE Levels
협력: 로슈
상세 →NCT06934200
2상모집 중단 (진행 중)· Obesity
A Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of RO7204239 in Combination With Tirzepatide in Participants With Obesity or Overweight With At Least One Weight-related Comorbidity
리드: 로슈
상세 →NCT06965413
2상모집 중단 (진행 중)· Cancer
A Phase 2 Clinical Trial Evaluating the Efficacy and Safety of Dual Immune Checkpoint Inhibition With Anti-PD-L1 (Atezolizumab) and Anti-TIGIT (Tiragolumab) in Cancer of Unknown Primary
협력: 로슈
상세 →NCT06754501
2상모집 중· Colorectal Carcinoma Metastatic in the Liver
Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC
협력: 로슈
상세 →NCT06555133
2상모집 중단 (진행 중)· Duchenne Muscular Dystrophy
A Study to Assess the Efficacy and Safety of Satralizumab in Duchenne Muscular Dystrophy (DMD)
리드: 로슈
상세 →NCT06450639
2상모집 중단 (진행 중)· Atopic Dermatitis
A Study to Assess the Efficacy and Safety of Afimkibart (RO7790121) in Participants With Moderate to Severe Atopic Dermatitis
리드: 로슈
상세 →NCT06863961
2상모집 중단 (진행 중)· Microsatellite Stable (MSS) Colorectal Cancer (CRC)
Trial of Atezolizumab, Bevacizumab, and Tiragolumab in Patients With Microsatellite Stable, Metastatic Colorectal Cancer
협력: 로슈
상세 →NCT06784947
2상모집 중· B-Cell Non-Hodgkins Lymphoma
A Study to Evaluate the Optimization of the Cytokine Release Syndrome Profile for Glofitamab in Combination With Gemcitabine Plus Oxaliplatin in Participants With Relapsed/Refractory Aggressive B-Cell Non-Hodgkin's Lymphoma
리드: 로슈
상세 →NCT06806033
2상모집 중· Lymphoma, Mantle-Cell
Phase II Study of Glofitamab With Venetoclax +/- Zanubrutinib in High-risk Mantle-cell Lymphoma
협력: 로슈
상세 →NCT06558604
2상모집 중단 (진행 중)· Mantle Cell Lymphoma
GATE1: A Multicenter Phase II Study of Pirtobrutinib, Rituximab and Venetoclax Combination Therapy for Patients With Previously Untreated Mantle Cell Lymphoma
협력: 애브비, 일라이 릴리, 로슈
상세 →NCT06522386
2상모집 중· Diffuse Large B Cell Lymphoma (DLBCL)
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
협력: 로슈
상세 →NCT06765317
2상모집 중· Muscle-invasive Urothelial Carcinoma
A Study to Evaluate the Efficacy and Safety of Autogene Cevumeran With Nivolumab Versus Nivolumab Alone in Participants With High-risk Muscle-invasive Urothelial Carcinoma (MIUC)
리드: 로슈 · 협력: 바이오엔테크
상세 →NCT06534983
2상모집 예정· Lung Cancer
A Study of Combining Cabozantinib and Atezolizumab for Advanced/Metastatic NSCLC (Cabatezo-1)
협력: 로슈
상세 →NCT05859217
2상모집 중단 (진행 중)· Overweight or Obese
A Study of Enicepatide (CT-388) in Participants Who Are Overweight or Obese With Type 2 Diabetes Mellitus
협력: 로슈
상세 →NCT06628362
2상모집 중· Extranodal Marginal Zone Lymphoma
Mosunetuzumab in Patients With Newly Diagnosed Extranodal Marginal Zone Lymphoma
협력: 로슈
상세 →NCT06569680
2상모집 중· Hairy Cell Leukemia
A Study of Vemurafenib and Obinutuzumab Compared to Cladribine and Rituximab in People With Hairy Cell Leukemia (HCL)
협력: 로슈
상세 →NCT06561360
2상모집 중· Large B-cell Lymphoma
A Trial of Polatuzumab Vedotin, Obinutuzumab and Glofitamab As a Peri-CAR-T Cell Treatment Strategy in Large B-cell Lymphoma
협력: 로슈
상세 →NCT06071871
2상모집 중· Extensive-stage Small-cell Lung Cancer
Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases
협력: 로슈
상세 →NCT05588388
2상모집 중단 (진행 중)· Chronic Lymphocytic Leukemia
A Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-treatment Period
리드: 로슈
상세 →NCT06524375

BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.